The OTC Monograph (non-prescription drug monograph) path cannot be judged solely by the product commonly known or by the “OTC” label. Enterprises need to check whether the active ingredient, agent type, adaptive condition, usage, warning phrases and labels meet applicable ad hoc conditions and to confirm, respectively, the registration of facilities, U.S. agent, Labeler Code, Drug Listing and the applicable costs.

Path boundary:Meeting the OTC Monograph conditions does not mean that the FDA has made a listing approval for the specific product. Further legal and regulatory assessments may be required if the product does not meet the conditions of specialization, is to make a declaration beyond the permitted limits or involves other special requirements; Do not use registration or NDC as a certificate of approval.

Preliminary check order for the OTC Monograph Path

  1. Identify products as pharmaceutical products and verify intended uses, adaptive conditions, active ingredients and formulations.
  2. Finds the applicable OTC Monochorph Order, item by item, matching formulations, conditions of use and labelling requirements.
  3. Identify facilities for manufacturing, processing, packaging, labelling, etc., and their registration responsibilities.
  4. Combine the applicable subjects and information in Labeler Code, NDC format and Drug Listing.
  5. Verify whether or not it belongs to the OMUFA facility and the applicable costs by statutory definition, distinguishing the cost of the facility from the OOMOR application fee.
  6. Establish review arrangements for labelling, product information, facility information and annual maintenance.

Common Confusion

  • OTC is a sales regulatory classification that does not automatically correspond to a monograph.
  • Facilities registration, Drug Listing and NDC are different matters and cannot substitute for product path judgement.
  • OMUFA costs are subject to a legal definition and not all pharmaceutical enterprises pay uniformly.
  • The requirements are different from the OTC Monochorph path if the new drug application or other path is followed.

Official sources

Date of official source check: 2026-10-27. The conformity of specific products with the applicable obligations is confirmed by the product facts and by the FDA current rules.

View OTC Compliance ServiceView pricing and order online ↗

Continue reading and preparation

Further consolidation of project information is availableOTC Monograph Path Support; The scope, processing cycles and costs are shown on the corresponding service page.